Lv52
1300 积分 2023-12-21 加入
Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial
1小时前
待确认
Endosomes are specialized platforms for bacterial sensing and NOD2 signalling
3小时前
待确认
TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study
14小时前
待确认
Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial
15小时前
待确认
Cryo-EM structure of the TL1A-DR3 complex and implications for the treatment of Inflammatory Bowel Disease
16天前
已完结
Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor
16天前
已完结
Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex
16天前
已完结
Taming the cytokine storm: small molecule inhibitors targeting IL-6/IL-6α receptor
16天前
已完结
Structure-Based Design of Small-Molecule Inhibitors of Human Interleukin-6
16天前
已完结
Interleukin-4 receptor signaling and its binding mechanism: A therapeutic insight from inhibitors tool box
16天前
已完结
皖公网安备34019202002308
